SAM
AUPH icon

Smartleaf Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Smartleaf Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.14K Sell
296
-461
-61% -$6.74K ﹤0.01% 2743
2025
Q4 		$12K Buy
757
+17
+2% +$241 ﹤0.01% 2310
2025
Q3 		$8.18K Buy
740
+214
+41% +$2.34K ﹤0.01% 2194
2025
Q2 		$4.54K Buy
526
+298
+131% +$2.39K ﹤0.01% 2085
2025
Q1 		$1.89K Sell
228
-651
-74% -$5.27K ﹤0.01% 2485
2024
Q4 		$8.06K Buy
879
+411
+88% +$3.35K ﹤0.01% 2076
2024
Q3 		$3.41K Buy
+468
New +$2.9K ﹤0.01% 2286

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smartleaf Asset Management's AUPH Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 61% in Q1 2026, selling an estimated $6.74K and leaving 296 shares worth $4.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Smartleaf Asset Management first reported a position in AUPH in Q3 2024 and has held it in 7 quarters since. The position peaked at $12K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Smartleaf Asset Management held 296 shares of Aurinia Pharmaceuticals worth $4.14K as of Q1 2026.
  • Smartleaf Asset Management sold 461 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $6.74K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2743 holding.
  • Smartleaf Asset Management first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Aurinia Pharmaceuticals position peaked at $12K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.